Abstract
Recruitment of eosinophils has long been recognized as a hallmark of the inflammatory response in asthma. However, the functions of this population of cells in host defense remain poorly understood. Eosinophils play an important part in the inflammatory response and have key regulatory roles in the afferent arm of the immune response. More recently, eosinophils have been demonstrated to participate in host defense against respiratory viruses. The specific contributions of eosinophils to the pathophysiology of asthma remain controversial. However, the balance of evidence indicates that they have a significant role in the disease, suggesting that they may be appropriate targets for therapy. Towards this end, a novel intervention of considerable potential interest is the use of an antibody directed against the β-common chain of the receptor for interleukin- 3, interleukin-5 and granulocyte-macrophage colony-stimulating factor. However, eliminating eosinophils may not be a risk-free therapeutic strategy, as there is potentially an increased likelihood of respiratory viral infections. This may predispose to the development of acute exacerbations of asthma, an outcome that would have significant clinical implications.
Keywords: Asthma, eosinophils, antiviral defense, interleukin-5 receptor, beta-common subunit
Current Molecular Medicine
Title: Targeting Eosinophils in Asthma
Volume: 8 Issue: 6
Author(s): Paul S. Foster, Helene F. Rosenberg, Kelly L. Asquith and Rakesh K. Kumar
Affiliation:
Keywords: Asthma, eosinophils, antiviral defense, interleukin-5 receptor, beta-common subunit
Abstract: Recruitment of eosinophils has long been recognized as a hallmark of the inflammatory response in asthma. However, the functions of this population of cells in host defense remain poorly understood. Eosinophils play an important part in the inflammatory response and have key regulatory roles in the afferent arm of the immune response. More recently, eosinophils have been demonstrated to participate in host defense against respiratory viruses. The specific contributions of eosinophils to the pathophysiology of asthma remain controversial. However, the balance of evidence indicates that they have a significant role in the disease, suggesting that they may be appropriate targets for therapy. Towards this end, a novel intervention of considerable potential interest is the use of an antibody directed against the β-common chain of the receptor for interleukin- 3, interleukin-5 and granulocyte-macrophage colony-stimulating factor. However, eliminating eosinophils may not be a risk-free therapeutic strategy, as there is potentially an increased likelihood of respiratory viral infections. This may predispose to the development of acute exacerbations of asthma, an outcome that would have significant clinical implications.
Export Options
About this article
Cite this article as:
Foster S. Paul, Rosenberg F. Helene, Asquith L. Kelly and Kumar K. Rakesh, Targeting Eosinophils in Asthma, Current Molecular Medicine 2008; 8 (6) . https://dx.doi.org/10.2174/156652408785748013
DOI https://dx.doi.org/10.2174/156652408785748013 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glutathione Modulation and Oxidative Stress in Human Liver Slices
Current Drug Discovery Technologies Allergic Contact Dermatitis: Novel Mechanisms and Therapeutic Perspectives
Current Drug Metabolism Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews Anti-Viral
Current Bioactive Compounds Vaccine Safety Monitoring Systems in Developing Countries: An Example of the Vietnam Model
Current Drug Safety Antagonists of CCR4 as Immunomodulatory Agents
Current Topics in Medicinal Chemistry New Approved Medications for Idiopathic Pulmonary Fibrosis
Current Drug Therapy Nicotine Replacement Therapy During Pregnancy and Lactation Induce Structural and Functional Changes in the Lungs of the Progeny
Current Women`s Health Reviews Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target
Current Cancer Therapy Reviews Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Oxygen Radicals on Bronchial Asthma
Current Drug Targets - Inflammation & Allergy Bronchiolitis Care in the Hospital
Reviews on Recent Clinical Trials Transdermal Drug Delivery: A Step towards Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Feasibility of Transcutaneous Method for Carbon Dioxide Monitoring in an Intensive Care Unit
Current Respiratory Medicine Reviews Administration of Drug and Nutritional Components in Nano-Engineered Form to Increase Delivery Ratio and Reduce Current Inefficient Practice
Recent Patents on Drug Delivery & Formulation Bronchial Thermoplasty for Severe Asthma: From Past to Present and Future
Current Respiratory Medicine Reviews Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Recent Advances in Ozonation of Vegetable Oils
Recent Patents on Materials Science Small Molecules that Promote Neurogenesis in vitro
Recent Patents on CNS Drug Discovery (Discontinued)